GlassScriptPhysician profile
Albert R Anderson
NPI 1013002435
$2,005.25
in general payments reported to CMS, 2019-2025
21 companies · $798 in 2025
The $798 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $57.23 · 2021: $127 · 2022: $18.74 · 2023: $62.01 · 2024: $757 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $629.06 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $228.63 | 2019-2021 | |
| Glaxosmithkline, LLC. | $200.11 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Neurocrine Biosciences, INC. | $144.98 | 2024 | Ingrezza |
| Boston Scientific Corporation | $133.32 | 2025 | Intracept |
| Amgen INC. | $92.20 | 2023-2025 | Prolia, Evenity, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.72 | 2020-2021 | |
| Shield Therapeutics INC | $66.33 | 2024 | |
| Lilly USA, LLC | $57.52 | 2024 | Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $55.00 | 2024-2025 | |
| Pfizer INC. | $49.83 | 2024-2025 | |
| Hologic Sales and Service, LLC | $45.22 | 2024 | Aptima |
| Novo Nordisk INC | $40.04 | 2023-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $37.83 | 2023-2024 | Ubrelvy |
| Merck Sharp & Dohme LLC | $35.40 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $23.36 | 2025 | Givlaari |
| Viiv Healthcare Company | $20.13 | 2024 | Apretude |
| Phathom Pharmaceuticals, INC. | $18.78 | 2025 | Voquezna |
| Medtronic, INC. | $17.62 | 2024 | Intellis Adaptivestim |
| Cequr Corporation | $13.62 | 2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.